Esketamine Receives Support from 2 FDA Committees

Esketamine, a drug developed by Johnson & Johnson for the treatment of depression has received support from two FDA committees. Final FDA approval is expected by March 2019. The drug has been approved for use in treatment resistant depression. From the...

Depression Treatment Gaithersburg

Are you currently experiencing the signs of major depression and don’t know where or how to get help? Perhaps you’ve experienced these symptoms before- starting early in your life- and you’re finding that each time to get depressed, it’s even...

Depression Research Study Participants Needed

Depression research study participants needed to take part in several clinical research trials exploring the effects of rapastinel, esketamine, and ketamine like compounds. Generally, research participants for these trials should: Be diagnosed with major depression Be...

Treatment Resistant Depression Clinical Trials Maryland

We are a clinical trials center located in Gaithersburg, Maryland. We work with patients nationwide, and provide transportation to eligible research participants within the Baltimore-Washington DC Metro Area.Depression is a difficult and painful condition; one that...

Major Depression: 5 signs

Major depressive episode is a psychiatric condition where someone feels depressed, most of the day, nearly every day, for at least two weeks. When someone experiences this kind of deep depression, and it lasts longer than two weeks, or if they experience multiple...
Translate »